Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telbivudine to Prevent Mother-to-Infant HBV Transmission
NCT01637844Phase 4Completed
- Start
- Apr 2012
- Primary completion
- Oct 2014
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of telbivudine in hepatitis B (HBV). Started Apr 2012; status: completed.
02
Drugs
telbivudine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01637844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01637844.